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Background: Panama is, economically, the fastest growing country in Central America and is making efforts to
improve management mechanisms for research and innovation. However, due to contextual factors, the
Panamanian Health Research System is not well developed and is poorly coordinated with the Health System.
Likewise, despite recent efforts to define a National Health Research Agenda, implementing this agenda and
aligning it with Panamanians’ health needs remains difficult. This articles aims to review Panama’s experience in
health research priority setting by analyzing the fairness of previous prioritization processes in order to promote an
agreed-upon national agenda aligned with public health needs.
Methods: The three health research prioritization processes performed in Panama between 2006 and 2011 were
analyzed based on the guidelines established by the four “Accountability for Reasonableness” principles, namely
“relevance”, “publicity”, “revision”, and “enforcement”, which provide a framework for evaluating priority-setting fairness.
Results: The three health research priority-setting events performed in Panama during the reference period
demonstrated a heterogeneous pattern of decision-making strategies, stakeholder group composition, and
prioritization outcomes. None of the three analyzed events featured an open discussion process with the scientific
community, health care providers, or civil society in order to reach consensus.
Conclusions: This investigation makes evident the lack of a strategy to encourage open discussion by the multiple
stakeholders and interest groups that should be involved during the priority-setting process. The analysis reveals the
need for a new priority-setting exercise that validates the National Agenda, promotes its implementation by the
National Secretariat for Science, Technology and Innovation in conjunction with the Ministry of Health, and empowers
multiple stakeholders; such an exercise would, in turn, favor the implementation of the agenda.
Keywords: Health research policy, Resources for researchBackground
Research prioritization for better health is recognized as
the key factor for countries to optimize the decision-
making process in order to establish their own research
policies and achieve better impacts through financial
investments [1]. Recently, broad concern has been raised
about how to set priorities in a transparent, systematic,
fair, and legitimate way in low- and middle-income coun-
tries [2-4]. The adequate fulfillment and implementation* Correspondence: lromero@usma.ac.pa
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article, unless otherwise stated.of such priorities may depend on the recognition of the
agenda by actor institutions and stakeholders. Despite the
fact that a universal method for priority setting for health
research does not exist, several strategies and methods
have been developed in order to facilitate prioritization
and have been applied to promote empowerment for deci-
sion making at the national and global level [5]. A recent
analysis of the prioritization experiences and methods
employed by a group of 18 Latin American and Caribbean
countries showed a wide variety of practices and achieve-
ments, indicating the need to use a systematic approach
to develop research priorities specific to each country’s
context [6].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Panama is recent; a National Health Research Agenda
acknowledged and embraced by the Health Ministry
(MINSA), the country’s governing health institution, has
not been developed. Further, a systematic analysis of the
practice has not been performed and prioritization has
not been discussed within the scientific community.
Moreover, the need to evaluate coordination between
health research priorities and local realities was acknowl-
edged during the Second Latin American Conference on
Research and Innovation for Health, which took place in
Panama City in November 2011 [7]. Thus, the objective
of this study was to examine Panama’s experience in
setting a National Health Research Agenda from a process
perspective in order to improve this practice and generate
agreement and fairness in future prioritization exercises.
Local context
Panama is a Central American country of 3.8 million
inhabitants and is considered the most promising econ-
omy in the region; it shows high-middle income eco-
nomic performance with a gross domestic product per
capita of 12,000 USD [8], the highest human develop-
ment index in Central America (0.780), and the fourth
highest index among Latin-American countries [9].
However, structural poverty and inequity still persist;
27.6% of the population lives below the poverty line, and
14.2% of the population lives in extreme poverty [10].
Indigenous groups compose 12.3% of the total popula-
tion and are the most affected by health disparities; this
disadvantage translates into high mortality and years of
potential life lost due to transmissible diseases [11]. This
pattern is different from that of the non-indigenous
population, in which mortality from non-transmissible
diseases predominates, reflecting the epidemiologic tran-
sition resulting from improved quality of life [12].
Panama does not have a universal health care system,
but its implementation has been under debate for several
years without a conclusion. Meanwhile, health services
and social security for over 60% of the population is pro-
vided by the Caja de Seguro Social (CSS) based on con-
tributions from employee salaries. The rest of the
population is covered by a network of MINSA hospitals
and health services. Together, the CSS and MINSA con-
stitute the Public Health System of Panama; investment
in this system is estimated at 1.3 billion USD, equivalent
to 5% of the GDP and 14% of the government’s total
expenditures [13].
As recently discussed in previous research [14], Panama
does not have a structured National Health Research
System (NHRS). This is related to historical factors,
such as the Panama Canal construction by the US gov-
ernment at the beginning of the 20th century. The
vector control for transmissible diseases, such as yellowfever and malaria, by William C. Gorgas in 1904,
marked a success for the Panama Canal construction
and the establishment of health research in the Pana-
manian isthmus [15]. In 1921, the Panamanian govern-
ment established the Gorgas Memorial Laboratory
(GML), which, under US administration, succeeded as
an active tropical disease research institute. For over six
decades, the GML was the only research institution in
the country, and its sustainability depended in large
part on the US until the 1990s [15], when the process
of returning the administration and territory of the
Panama Canal to Panamanian control began. The in-
corporation of the GML, now Gorgas Commemorative
Institute of Health Studies (ICGES), into the National
Health System in 1990 began the structuring of the
local NHRS.
In 2003, the ICGES was restructured through Law 78
into a public, social interest entity with legal, financial,
and technical autonomy, responsible for conducting and
stimulating the development of national health research
in coordination with MINSA [16]. However, neither
MINSA nor ICGES has dictated an agenda of national
priorities for health. Instead, the Plans of the National
Secretariat for Science, Technology and Innovation
(SENACYT) prevail. SENACYT, which is the key institu-
tion for promoting research activities, innovation, and
human resources training for all knowledge areas in the
country, was founded in 1992 as a joint organization of
the Panamanian Presidency [17]. The institution had
jurisdiction over policies and resources to accomplish its
function until 2005 [17], when the National Strategic
Plan for Science, Technology, and Innovation (PENCYT)
became the means to execute research priorities, includ-
ing the health research agenda. However, the implemen-
tation of PENCYT agendas has been compromised by
the low level of local public investment in research and
development activities, including the suspension of
research funds during the last two years. According to
recent data [18], Panama invested 0.19% of its GDP in
research and development in 2010, which is four times
below the average for Latin American and Caribbean
countries, estimated at 0.78% of GDP. Official data indi-
cate that Panama’s cumulative public investment in
research and development, awarded through competitive
grants from SENACYT between 2004 and 2012, was
$18.6 million dollars. These funds have been assigned to
340 research projects in all knowledge areas, of which
63 (18.5%) correspond to health sciences [19]. The
ICGES and the Institute for Scientific Research and
Technology Services (INDICASAT) are the leading
research institutions in the country and are the main re-
cipients of these research funds, as indicated in Table 1.
According to the World Health Organization, a health
research prioritization process is defined as a scheme to
Table 1 Distribution of public fund for health research
during the years 2004 to 2012
Institution Project (n) Investment (%)
Gorgas Commemorative Institute
of Health Studies (ICGES)
26 38.0
Institute for Scientific Research and
Technology Services (INDICASAT)
20 39.9
University of Panama (UP) 6 9.3
Health Ministry (MINSA) 2 6.2
Social Security (CSS) 2 2.8
Others 7 3.8
Total 63 100
Elaborated from official data from SENACYT [19].
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urgent attention [20]. A priority is defined as an element
or condition judged to be more important than another,
which involves an exercise in “judgment” and the use of
“values” that sustain the quality of a priority [21]. Simul-
taneously, there is a local context and a series of criteria,
such as benefits, evidence, cost-efficiency, equity, and
severity, which compete in order to establish this
judgment. Finally, stakeholders, who act individually in
representation of pluralist society, make decisions by
consensus, making an ethical framework necessary to
sustain the legitimacy of the prioritization process [2,20].
This group of stakeholders includes individuals from the
governmental sector, non-governmental organizations,
the private sector, academia, health service providers,
and healthcare recipients. The intention of this plurality
is to encourage equal participation among the different
sectors involved and to allow constructive debate for
conflict resolution between different areas and interests
[2]. An explicit prioritization process strategy and a de-
scription of follow-up plans are other key elements that
guarantee the process’ transparency and legitimacy [2];
transparency refers to the extent to which it is clear how
decisions were made and legitimacy refers to the moral
authority of decision makers [22,23].
Daniels and Sabin [22,24] established the process of
“accountability for reasonableness” (AR) with the aim to
prevent errors that can be committed by legitimate au-
thorities. AR represents the ethical framework of a legit-
imate prioritization process as it encourages democratic
deliberation through four conditions based on justice
theory: relevance, publicity, review, and enforcement.
The condition of “relevance” is met if prioritization deci-
sions are based on importance as recognized by legitim-
ate decision makers. In order to meet this condition,
careful selection of a representative group of decision
makers who are responsible for the elucidation of values,
criteria, methods, and information that will guide the
prioritization process is necessary. The condition of“publicity” is achieved if the decisions and reasons for
the prioritization are made available to encourage public
debate. To meet the condition of “review”, mechanisms
for the reevaluation of decisions based on new evidence
should exist. Finally, to ensure a just process, the leaders
must guarantee the three previous conditions are met,
therefore meeting the fourth condition of “enforcement”
[1,25]. Recently, the AR approach has been implemented
in priority-setting for health care services [26,27] and
health research [28,29], relying on the belief that fair,
deliberative procedures yield acceptable results [26].
The principal objective of establishing research prior-
ities for health at the domestic or international level is
to align investments with the population’s health needs
in an efficient way to improve health and quality of life.
However, prioritization represents one of the greatest
challenges confronted by decision makers, particularly in
less developed countries where there are obstacles, in-
cluding limited economic resources, insufficient official
health indicators, socioeconomic inequity, political in-
stability, and inefficient health institutions and systems
[1,30]. At the same time, one of the largest challenges is
the lack of equal participation among decision makers
and the shortage of systematic strategies for adequate
prioritization processes [31]. As a result, at times,
countries set priorities based on historical precedents or
by forming ad hoc committees [31]. These prioritization
practices frequently generate results that are not in line
with reality or that are influenced by the preferences and
scientific autonomy of researchers [31].
Systematic prioritization process experiences of low-
and middle-income countries in Africa, Asia, and Latin
America have been documented [2,5,6]. Authors report
high heterogeneity among the different countries exam-
ined in areas such as the context, methods used, criteria
included, information used, involvement of different
stakeholder groups, results obtained, and prioritization
processes [2]. In the Latin American context, the leader-
ship of Brazil has been recognized for the transparency
of its processes, the inclusion of broad stakeholder
groups, and the maturity of its health research system.
Brazil’s prioritization is based on a high degree of public
consultation throughout the process, which was led by
the Ministry of Health in 2003 and followed the Com-
bined Approach Matrix methodology. The first draft of
the agenda was written by a group of 510 professionals
from five different regions [32], and it was available for
public comment over 45 days on the Ministry of Health’s
official website. A series of municipal, state, and national
conferences constituted the preparatory phase with the
community before the agenda was approved during the
Second National Conference on Science, Technology,
and Innovation in 2004. The event included the partici-
pation of 431 conference delegates and 213 observers
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construction of the agenda: 1) improve public health in
the short, medium, and long term; 2) eliminate all forms
of inequality and discrimination; 3) respect the life and
dignity of people; 4) ensure the implementation of high
ethical and gender standards in research; 5) respect
methodological and philosophical pluralism; and 6) strive
for social inclusion and environmental respect [32]. Thus,
if evaluated with the AR principles in mind, the described
country experience illustrates the establishment of a com-
prehensive national agenda with a high level of legitimacy
based on deliberative practices for consensus building and
transparency.
Methods
This qualitative study was based on the analysis of
agenda setting for health research performed in Panama
between 2006 and 2011, after science and technology
management mechanisms were established in the coun-
try. The three prioritization events identified were docu-
mented in key official documents from SENACYT,
available via the transparency module of its official web-
page (http://www.senacyt.gob.pa): the PENCYT 2006–
2010 [17], the PENCYT 2010–2014 [33], and the “Final
report on the inter-sectoral and inter-institutional work-
shop on health research policies and priorities” [34]. The
conceptual framework for this analysis was based on the
four AR principles of “relevance”, “publicity”, “revision”,
and “enforcement” [22-24]. Table 2 provides a summary
of this methodology and its application to this study.
Results
Priority-setting processes description
Panama has no exclusive policy regarding research and
innovation for health. Instead, the PENCYT acts as
SENACYT’s official plan and operative instrument. The
PENCYT is established every five years and is composed
of seven sectoral plans, including one on health. Three
PENCYTs have been written since SENACYT was estab-
lished in 1992. The first one corresponded to the years
1998 to 2000 [17]. During the following 6 years, theTable 2 Description of the “Accountability for Reasonablenes
Condition *As described
Relevance Rationales must rest on evidence, reasons, and principle
that all fair-minded parties can agree
Publicity Decisions and their rationales must be publicly accessib
Revision Mechanism for revising decisions in light of further evid
or arguments
Enforcement A process to ensure that the first three conditions are m
*From references [22-24].
**As described in Methods.country operated without an official plan until the
PENCYT 2006–2010 was officially approved [17]. The
current PENCYT corresponds to the 2010–2014 period
[33]. To implement the plans, SENACYT established
the science and technology management mechanisms
in 2005. Therefore, for the purposes of this study, only
the three prioritization exercises performed after 2005
were analyzed.
Two prioritization processes took place to establish
the PENCYT 2006–2010. During the first process [Prior-
ity-setting I], the “Sectoral plan for health research and
innovation” was elaborated by an ad hoc Health Commis-
sion, which consisted of six researchers from only two in-
stitutions (ICGES and Children’s Hospital) (Table 3) [17].
Once placed within the context of the country’s health
situation using health data, the Commission proceeded
with the identification of priorities for the transformation
of the national public health situation, a vision that guided
the construction of nine themes, as illustrated in Table 4.
The plan, which became official in February of 2007, did
not pass through a consultation process with the scientific
community, nor was it made available for public comment
or consultation before being approved. During the same
year, PENCYT 2006–2010 underwent an external mid-
term review process. This review recognized that a
systematic prioritization exercise was needed for health
research to complement the Priority-setting I process.
According to the AR framework, Priority-setting I met
the “relevance” principle as epidemiological evidence
was analyzed to determine the relevance of problems to
be discussed, but the process failed to satisfy the “publi-
city” criterion when PENCYT 2006–2010 was approved
without community consultation. The “revision” principle
was also met as the plan was submitted to external evalu-
ation; however, the process failed to meet the “enforce-
ment” criterion, which requires leadership engagement to
meet the three previous conditions.
The second prioritization process [Priority-setting II] was
performed following PENCYT’s external mid-term review
process, which recognized that a systematic prioritization
exercise was needed. The prioritization event was organizeds” conditions
**As applied in this study
s Assessing the use of evidence, principles or criteria to stand
the decisions taken during the priority setting process
le Assessing the access of the defined priority agenda and
its public discussion previous to its official approval
ence Assessing the agenda reevaluation and actualization
following external or internal discussion/evaluation
et Assessing the leaders engagement for the accomplishment
of the previous conditions
Table 3 Comparative analysis according to the criteria of Accountability for Reasonableness (AR) between different
health research prioritization processes in Panama, 2006 to 2012
Decision makers Criteria
Plan Committee Institution (n) Relevance Publicity Review Reinforcement





Priority-setting II: Pluralist participation of 65
actors from the public and
private sector, government,
academia and ST&I management
MINSA (25), ICGES (13),
UP (7), HST (5),
COHRED (1),







SENACYT (1), CSS (1),
Comptroller (2),
ANAM (1), Private (1),
INDICASAT (1),
HN (2), MIDA (4),
NGO (1)
Priority –setting III: Ad Hoc committee of 13 actors
and 3 collaborators
MINSA (4), ICGES (2),
CSS (2),
Present Not present Present Not present
PENCYT 2010-2014 UP (2), NGO (1)
STRI (1), HN (1)
UP (1), INDICASAT (1),
Government (1)
ANAM, Autoridad Nacional del Ambiente (National Environmental Authority); COHRED, Council on Health Research for Development; CSS, Caja del Seguro Social;
HN, Hospital del Niño (Children’s Hospital); HST, Hospital Santo Tomás; ICGES, Gorgas Commemorative Institute of Health Studies; INDICASAT, Institute for
Scientific Research and Technology Services; MIDA, Ministerio de Desarrollo Agropecuario (Ministry of Agricultural Development); MINSA, Health Ministry; NGO,
Non-governmental organization; PENCYT, National Strategic Plan for Science, Technology, and Innovation; SENACYT, National Secretariat for Science, Technology
and Innovation; STRI, Smithsonian Tropical Research Institute; UP, Universidad de Panamá.
Source: Elaborated from official documents available from SENACYT’s webpage [17,33,34].
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and inter-institutional workshop on health research policies
and priorities”, which took place in November 2007 [34]. In
this case, the priority-setting exercise was led by ICGES
and was conducted in consultation with the Council on
Health Research for Development (COHRED) [34], a glo-
bal, non-profit organization that supports the development
of research systems in low- and middle-income countries.
The process was based on the Hanlon method [34], a quan-
titative tool designed to rank selected health problems
according to specific criteria in order to reach consensus
among a wide participation of actors [35]. Thus, in Priority-
setting II, the work group comprised 65 participants includ-
ing researchers, managers, academics, decision makers,
and members of civil society from different regions of
the country (Table 3). The participants were divided
into six working groups coordinated by two facilitators.
To initiate the prioritization, the most important health
issues were previously categorized into six general areas
as indicated in Table 4. For each area, five specific
problems were discussed and subjected to four evalu-
ation criteria using a quantitative scale: magnitude (A),
severity (B), cost-efficiency (C), and feasibility of inter-
vention (D). The results obtained were incorporated into a
single prioritization matrix and then tabulated using a
formula [priority = (A + B) × C ×D] to obtain a final quan-
titative value, as detailed by the documentation generatedduring the prioritization process [34]. The results were
then ranked from highest to lowest numerical value to ob-
tain an order of prioritized problems (Table 4). However,
the results of this process were not incorporated into the
PENCYT, nor were they assimilated by MINSA at the
time.
When evaluated according to the AR criteria, Priority-
setting II met the “relevance” principle because epidemio-
logical evidence was reviewed prior to the discussion. In
addition, a well-defined, systematic prioritization method
with clear selection criteria was applied and its strategy
was explicit. However, with regards to “publicity”, this
criterion was not met; despite efforts to ensure plurality
of the decision-making group to promote agreement in the
absence of public consultation, an imbalance in representa-
tion was observed. For instance, the CSS, which provides
public health care services to over 60% of the population,
was underrepresented with only one participant (1/65),
compared to 25 (25/65) participants from MINSA [34]. An-
other important actor institution that was not represented
was the National Oncologic Institute; this institution pro-
vides health services to all Panamanian patients with cancer
and malignancies, which are the second leading cause of
death in the country [36]. As there was no “revision” of
decisions in light of new evidence documented at the time,
and “enforcement” of all the principles was not observed,
these criteria were not met in Priority-setting II.
Table 4 Structure of the agenda of priorities generated by the health research prioritization processes conducted in
Panama, 2006 to 2015
Plan/Policy Structure and priorities
Sectoral plan of research and innovation
in health- PENCYT 2006–2010 [17]
(Priority-setting I)
Structured into nine Health Themes:
1- Consolidation of health research as a generator of evidence for decision making.
2- Reinforcement of research in prioritized disease and mortality themes (non-transmissible diseases).
3- Reinforcement of research for the prevention and control of transmissible diseases.
4- Reinforcement of research in health management, public health, and service provision.
5- Utilization of the System to achieve better impact from health actions.
6- Determination of social factors and risk factors of disease.
7- Development of a health research system.
8- Development of research in technology evaluation.
9- Strengthen the capacity of ICGES’s leadership.
Inter-sectoral and inter-institutional workshop
on policies and priorities in health research
2007 [33] (Priority-setting II)
Structured into six General Areas:
1- Health and environment: water contamination/exposure to transmissible disease vectors.
2- Behavior and lifestyle: nutrition/problems linked to exposure to social risks.
3- Education and citizen participation: health education/awareness of rights and responsibilities in health.
4- Disease burden and mortality: transmissible diseases/emergent and re-emergent diseases.
5- Health services: organization of services/quality of services.
6- Inequality in health: inequality in resources in services offered/distribution of mortality, life
expectancy, YPLL, birth weight, median school-age, height, and psychomotor development.
National ST&I Program for the Development
of Biosciences and Health Sciences/PENCYT
2010–2014 [34] (Priority-setting III)
Complex structure simultaneously applied to biosciences and health sciences:
1- Priority actions for human resources reinforcement.
2- Priority areas in bioscience and health science training.
3- Priority actions at the level of research and development in biosciences and health sciences.
4- Priority thematic areas in R&D in biosciences and health sciences:
a) Prioritization workshop areas (COHRED-SENACYT 2007) (see previous plan).
b) Research priorities associated with specific diseases in the short, medium, and long term.
c) Other thematic priorities in research and health determinants.
d) Priorities at the level of innovation (national registry system of research projects and others).
COHRED, Council on Health Research for Development; ICGES, Gorgas Commemorative Institute of Health Studies; SENACYT, National Secretariat for Science,
Technology and Innovation; PENCYT, National Strategic Plan for Science, Technology, and Innovation; YPLL, Years of potential life lost.
Source: Elaborated from official documents available from SENACYT’s webpage [17,33,34].
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presented a new opportunity for organizing the agenda
[Priority-setting III] [33]. In contrast to the previous
PENCYT, in which biosciences and health were main-
tained in separate plans, the current PENCYT 2010–
2014 integrated both areas into the “National Program
of Science, Technology and Innovation for the Develop-
ment of Biosciences and Health Sciences”. The Plan’s
priorities were determined by an ad hoc Sectoral Com-
mission made up of 13 actors and 3 collaborators led by
a coordinator from the University of Panama (Table 3).
The group of stakeholders from the Sectoral Commis-
sion with a decision-making function was composed
mostly of researchers representing public research insti-
tutions (n = 3), health care facilities (n = 1), academia
(n = 2), non-governmental organizations (n = 1), and anon-Panamanian research institution (n = 1). Minor stake-
holder representation corresponded to policy makers from
health (n = 4) and science and technology (n = 1) govern-
mental institutions.
Once the evidence was reviewed and an analysis of the
sector’s strengths, weaknesses, opportunities, and threats
was completed, the Commission produced a series of
priorities grouped into different categories with a com-
plex structure. As illustrated in Table 4, the first four
categories were organized as actions and areas for scien-
tific research strengthening and development in both
health and biosciences (biology, biodiversity, ecology, and
environment). The identified problems from Priority-
setting II were then incorporated into the priority list. This
was followed by formulating a new category of “research
priorities linked to specific diseases”, which were separated
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thematic research priorities” were added. Finally, two “pri-
orities at the level of innovation” were incorporated: 1) a
national registry system of researchers and research pro-
jects and 2) access to scientific publication databases. A
series of action lines and strategies were dictated for
achieving these priorities and when finished, the PENCYT
2010–2014 passed through an approval process with the
Cabinet Council in December 2010. The Plan is available on
SENACYT’s official webpage (http://www.senacyt.gob.pa)
but did not pass through a consultation process with the
scientific community. This plan was recently subjected to
an external evaluation of medium-term validity to assess its
implementation.
According to the AR approach, Priority-setting III met
the “relevance” principle as health evidence was widely
analyzed before the prioritization exercise. The “revi-
sion” criterion was partially met; the implementation of
the plan but not the selection of themes during the
prioritization process was reviewed by an external com-
mission. On the other hand, the “publicity” principle was
not satisfied as decisions were made in a closed event by
a small committee without public discussion. This lack
of open participation also had a negative impact on the
principle of “enforcement”, which reassures that the
three previous principles have been met.
Discussion
Currently, there is an increased emphasis on health re-
search prioritization in a transparent and legitimate way
[5], particularly because important economic decisions
regarding public funding are derived from prioritization
outcomes. However, prioritization is difficult to perform
as the process depends on the application of a series of
criteria and values interpreted by many different actors
according to the socioeconomic and political context
where the process occurs. Based on these levels of com-
plexity and responsibility, the objective of the present
analysis is to promote critical evaluation of the health re-
search priority-setting experience in Panama to optimize
decision making in order to form an agreed-upon health
research agenda in accordance with public health needs.
The present study analyzed Panama’s most recent
prioritization processes based on the AR conditions
[22,24] with the objective to identify good practices and
opportunities for improvement. The short history of the
NHRS in Panama reveals limited experience in system-
atic decision making for health research prioritization,
particularly in a participatory and decentralized practice
[15,37]. The results of the prioritization processes pre-
sented in this analysis reflect the evolving health re-
search situation in the country during recent years; from
1921 to only a decade ago, research was sustained predom-
inantly by one institution focused primarily on tropical,transmissible diseases, the ICGES. The second institution
in the country dedicated to biomedical and environmental
research, INDICASAT, was established in 2002. Only in re-
cent years have research groups been organized at both in-
stitutes and competitive local scientific production started.
On the other hand, clinical research has been sustained by
a few research groups in some hospitals and health centers
within the country. In a number of cases, this research is
related to the application of a pre-defined protocol for
multi-center drug and vaccine clinical trials, which are
often not considered local scientific production. The Uni-
versity of Panama, the country’s main university, has few
research groups in the basic sciences and has maintained
low and sustained productivity in the areas of pharmacol-
ogy, parasitology, chemistry, and molecular biology [14].
Based on the present analysis, one can understand why a
balanced representation of actors was not observed in
Priority-setting I and II. The intention to overcome this
limitation during Priority-setting II improved the plurality
factor; this exercise was based on a wide participation of
stakeholders in the fields of health care and health research
and from civil society; however, balanced participation
among the health system actors was not achieved. The
health care participant groups were not equally repre-
sented: MINSA (25/65) vs. CSS (1/65). The CSS, the
underrepresented institution, provides health assistance to
over 60% of the Panamanian population and takes on the
high cost of non-transmissible diseases, the main cause of
death in the country. The lack of equal participation by de-
cision makers has been identified by COHRED as a source
of potential errors that can influence the prioritization
process and its results [38]. To this problem we can add
the potential risk for a lack of agenda receptivity and own-
ership by stakeholders and actor institutions.
The formulation of the PENCYT 2010–2014 provided
a new opportunity to overcome the equal representation
challenges of the previous processes. However, the
reduced size of the commission and the composition of
actors, including only researchers (n = 7) and policy
makers (n = 5), limited wider participation by other
actors; decisions were made based on the ad hoc com-
mission’s perspective in a closed event.
Among the risks encountered when prioritization pro-
cesses lack consultation and consensus by a wide group
of actors is that the prioritization results are not in
accordance with the public health plans that the country
needs. The limited representation of health care pro-
viders and health service users in the discussion may
have caused service quality and health equity to be over-
looked as health issues needing attention. In addition to
the need to promote participation by more actors in the
decision-making process, there is also a need to improve
agreement on health problems relevant to the general
population. Public consultation to reach consensus has
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http://www.health-policy-systems.com/content/12/1/38been a mechanism through which other Latin American
countries, such as Brazil, Colombia, and Peru, have
established health priority agendas and legitimized the
decision-making process [4,6].
The theme of health research in the plans analyzed in
the present study deserves clear discussion as it overlaps
with the area of biosciences within the current PENCYT
2010–2014. In this case, health research has been cate-
gorized as a biological discipline, which maintains the
biotechnology paradigm as the primary axis for estab-
lishing the agenda. On the other hand, we must consider
that health frequently overlaps with the social, environ-
mental, and agricultural sectors [4], among others. As a
result of the simultaneous approach to bioscience and
health, the priorities written in the current plan are am-
biguous, the structure is difficult to understand, and its
implementation by health institutions is difficult. These
factors represent an obstacle to the basic function of pri-
ority setting, which is to identify important health issues
and mobilize the resources needed to address them. In
the ideal case, the agenda represents agreed-upon topics
or health problems resulting from a prioritization process
and becomes the policy instrument that mobilizes the
health research system through specific calls for proposals
and resource allocations [39]. Consequently, a national
research portfolio aligned with population health needs to
generate evidence for health improvement and country
development is the overall objective of health research.
Therefore, establishing a national agenda using public
health and equity lenses to address the problems most
affecting the Panamanian population, such as non-
communicable diseases, population aging, and deaths
due to accidents and violence, as well as health promo-
tion and disease prevention, remains the objective for
the next prioritization exercise. Ensuring fairness of the
priority-setting process by including a wide range of
stakeholders and an open discussion is the means by
which a comprehensive plan that is recognized by differ-
ent interest groups can be formed. Last but not least, a
unified vision of health and science and technology
government institutions that prioritizes and guarantees
investment in health research is the overarching goal
that will assure implementation of a national health
research agenda.
Conclusions
This analysis reveals the need to rethink a health re-
search prioritization strategy in which wide participation
from stakeholders working towards consensus at the na-
tional level is included. With this, the prioritization
process’ legitimacy will be improved, the health research
policy will be strengthened, and the agenda can be struc-
tured to be aligned with public health needs in order to
improve the population’s health and quality of life.Abbreviations
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